UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor mutation burden (TMB) estimation using small-sized targeted next-generation sequencing (NGS) to predict efficacy of immune checkpoint inhibitors (ICIs) for non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii509-viii509

2018

Volltextzugriff (PDF)

Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial

ESMO open, 2024-05, Vol.9 (5), p.103444, Article 103444

2024

Volltextzugriff (PDF)

MS 05.04 Practical Approach to Combination of Chemotherapy with IO

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1677-S1677

Ohe, Y.

2017

Volltextzugriff (PDF)

Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study

Annals of oncology, 2018-11, Vol.29, p.ix177-ix177

2018

Volltextzugriff (PDF)

Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM

ESMO open, 2024-04, Vol.9 (4), p.102975-102975, Article 102975

2024

Volltextzugriff (PDF)

Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancer

Japanese journal of clinical oncology, 2014-09, Vol.44 (9), p.846-851

2014

Volltextzugriff (PDF)

MA 19.01 A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT)

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1883-S1883

2017

Volltextzugriff (PDF)

463 Multiplex detection of 17 kinds of oncogenic fusion and aberrant transcripts in formalin-fixed, paraffin embedded tissues of lung adenocarcinoma by molecular counting

European journal of cancer (1990), 2015-09, Vol.51, p.S99-S99

2015

Volltextzugriff (PDF)

Acute Toxicities and Dose-Volume Histogram Parameters for Organs at Risk in Proton Beam Therapy for Stage III Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S607-S607

2014

Volltextzugriff (PDF)

First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients

ESMO open, 2022-02, Vol.7 (1), p.100394-100394, Article 100394

2022

Volltextzugriff (PDF)

Updated Data of a Phase 1/2 Study (AF-001JP) of Alectinib, a CNS-Penetrant, Highly Selective ALK Inhibitor in ALK -rearranged Advanced NSCLC

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S6-S6

2014

Volltextzugriff (PDF)

Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell carcinoma of the lung

Annals of oncology, 2011-11, Vol.22 (11), p.2471-2475

2011

Volltextzugriff (PDF)

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

Annals of oncology, 2005-03, Vol.16 (3), p.430-436

2005

Volltextzugriff (PDF)

3043 Clinicopathological features of patients with ROS1-rearranged advanced non-small cell lung cancer: LC-SCRUM-Japan

European journal of cancer (1990), 2015-09, Vol.51, p.S610-S610

2015

Volltextzugriff (PDF)

Dual antiplatelet therapy clopidogrel with low dose cilostazol intensified platelet inhibition in patients with ischemic stroke

Journal of the neurological sciences, 2013-10, Vol.333, p.e176-e176

2013

Volltextzugriff (PDF)

A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients

Annals of oncology, 2004-01, Vol.15 (1), p.45-50

2004

Volltextzugriff (PDF)

Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials

British journal of cancer, 2009-04, Vol.100 (7), p.1037-1042

2009

Volltextzugriff (PDF)

Gender difference in hematological toxicity among lung cancer patients receiving amrubicin monotherapy

Japanese journal of clinical oncology, 2012-12, Vol.42 (12), p.1187-1191

2012

Volltextzugriff (PDF)

EP.12A.31 Clinical Characteristics and Outcomes of EGFR-Positive Non-Small Cell Lung Cancer with Acquired RET Fusions

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S633-S633

2024

Volltextzugriff (PDF)

502P Impact of sarcopenia on the outcome of patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab

Annals of oncology, 2023-11, Vol.34, p.S1659

2023

Volltextzugriff (PDF)

Nanosecond High Voltage Pulse Generator Using Water Gap Switch for Compact High Power Pulsed Microwave Generator

IEEE transactions on dielectrics and electrical insulation, 2007-08, Vol.14 (4), p.894-899

2007

Volltextzugriff (PDF)

1495P Impact of social isolation on the clinical outcomes in advanced NSCLC patients

Annals of oncology, 2024-09, Vol.35, p.S918-S919

2024

Volltextzugriff (PDF)

1920P Multiomics analysis of malignant pleural mesothelioma and the effect of immune checkpoint inhibitors

Annals of oncology, 2024-09, Vol.35, p.S1117-S1117

2024

Volltextzugriff (PDF)

669P Patient-reported outcomes with selpercatinib in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial

Annals of oncology, 2023-10, Vol.34, p.S470-S471

2023

Volltextzugriff (PDF)

Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer

European journal of cancer (1990), 2001, Vol.37 (1), p.54-63

2001

Volltextzugriff (PDF)

26 – 50 von 1.215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(957)
Mit Volltextzugriff
(978)

Publikationsform

Sprache

Englisch
(1.071)
Japanisch
(163)
Französisch
(3)
Deutsch
(1)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(547)
Humans
(445)
Life Sciences & Biomedicine
(427)
Male
(325)
Female
(277)
Middle Aged
(246)
Biological And Medical Sciences
(229)
Aged
(196)
Adult
(195)
Medical Sciences
(195)
Oncology
(140)
Animals
(126)
Physical Sciences
(113)
Lung Neoplasms - Drug Therapy
(92)
Chemistry
(89)
Pharmacology. Drug Treatments
(84)
Cardiovascular System & Cardiology
(69)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(64)
Cardiac & Cardiovascular Systems
(62)
Aged, 80 And Over
(55)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Tumor mutation burden (TMB) estimation using small-sized targeted next-generation sequencing (NGS) to predict efficacy of immune checkpoint inhibitors (ICIs) for non-small cell lung cancer (NSCLC)

Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial

MS 05.04 Practical Approach to Combination of Chemotherapy with IO

Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study

Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM

Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancer

MA 19.01 A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT)

463 Multiplex detection of 17 kinds of oncogenic fusion and aberrant transcripts in formalin-fixed, paraffin embedded tissues of lung adenocarcinoma by molecular counting

Acute Toxicities and Dose-Volume Histogram Parameters for Organs at Risk in Proton Beam Therapy for Stage III Non-Small Cell Lung Cancer

First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients

Updated Data of a Phase 1/2 Study (AF-001JP) of Alectinib, a CNS-Penetrant, Highly Selective ALK Inhibitor in ALK -rearranged Advanced NSCLC

Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell carcinoma of the lung

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

3043 Clinicopathological features of patients with ROS1-rearranged advanced non-small cell lung cancer: LC-SCRUM-Japan

Dual antiplatelet therapy clopidogrel with low dose cilostazol intensified platelet inhibition in patients with ischemic stroke

A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients

Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials

Gender difference in hematological toxicity among lung cancer patients receiving amrubicin monotherapy

EP.12A.31 Clinical Characteristics and Outcomes of EGFR-Positive Non-Small Cell Lung Cancer with Acquired RET Fusions

502P Impact of sarcopenia on the outcome of patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab

Nanosecond High Voltage Pulse Generator Using Water Gap Switch for Compact High Power Pulsed Microwave Generator

1495P Impact of social isolation on the clinical outcomes in advanced NSCLC patients

1920P Multiomics analysis of malignant pleural mesothelioma and the effect of immune checkpoint inhibitors

669P Patient-reported outcomes with selpercatinib in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial

Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer

Suchergebnisse filtern